- Home
- PRQR vs DRDB Comparison
PRQR vs DRDB Comparison
Compare PRQR & DRDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- DRDB
- Stock Information
- Founded
- PRQR 2012
- DRDB 2024
- Country
- PRQR Netherlands
- DRDB United States
- Employees
- PRQR N/A
- DRDB N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- DRDB
- Sector
- PRQR Health Care
- DRDB
- Exchange
- PRQR Nasdaq
- DRDB Nasdaq
- Market Cap
- PRQR 179.1M
- DRDB 316.5M
- IPO Year
- PRQR 2014
- DRDB 2024
- Fundamental
- Price
- PRQR $2.18
- DRDB $10.32
- Analyst Decision
- PRQR Strong Buy
- DRDB
- Analyst Count
- PRQR 8
- DRDB 0
- Target Price
- PRQR $8.88
- DRDB N/A
- AVG Volume (30 Days)
- PRQR 371.0K
- DRDB 111.2K
- Earning Date
- PRQR 08-07-2025
- DRDB 01-01-0001
- Dividend Yield
- PRQR N/A
- DRDB N/A
- EPS Growth
- PRQR N/A
- DRDB N/A
- EPS
- PRQR N/A
- DRDB N/A
- Revenue
- PRQR $21,212,711.00
- DRDB N/A
- Revenue This Year
- PRQR N/A
- DRDB N/A
- Revenue Next Year
- PRQR N/A
- DRDB N/A
- P/E Ratio
- PRQR N/A
- DRDB $590.11
- Revenue Growth
- PRQR 85.91
- DRDB N/A
- 52 Week Low
- PRQR $1.07
- DRDB $9.87
- 52 Week High
- PRQR $4.62
- DRDB $10.43
- Technical
- Relative Strength Index (RSI)
- PRQR 65.20
- DRDB N/A
- Support Level
- PRQR $1.89
- DRDB N/A
- Resistance Level
- PRQR $2.54
- DRDB N/A
- Average True Range (ATR)
- PRQR 0.13
- DRDB 0.00
- MACD
- PRQR 0.01
- DRDB 0.00
- Stochastic Oscillator
- PRQR 39.85
- DRDB 0.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About DRDB Roman DBDR Acquisition Corp. II Ordinary shares
Roman DBDR Acquisition Corp II is a blank check company.